Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$1.46 - $3.55 $3,476 - $8,452
-2,381 Closed
0 $0
Q2 2021

Aug 06, 2021

BUY
$9.43 - $16.6 $6,534 - $11,503
693 Added 41.05%
2,381 $33,000
Q1 2021

May 14, 2021

BUY
$9.71 - $18.6 $5,389 - $10,323
555 Added 48.98%
1,688 $18,000
Q1 2019

May 15, 2019

BUY
$7.5 - $15.31 $5,700 - $11,635
760 Added 203.75%
1,133 $9,000
Q2 2018

Aug 13, 2018

BUY
$11.39 - $16.26 $4,248 - $6,064
373 New
373 $4,000

About Evelo Biosciences, Inc.


  • Ticker EVLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,994,000
  • Description
  • Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...
More about EVLO
Track This Portfolio

Track Ameritas Investment Partners, Inc. Portfolio

Follow Ameritas Investment Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.